本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Entera Bio Ltd.

1.78
-0.0450-2.47%
成交量:3.48万
成交额:6.29万
市值:8,067.76万
市盈率:-6.91
高:1.86
开:1.85
低:1.77
收:1.82
数据加载中...
2022/05/16

重要事件披露

8-K - Current report
2022/05/12

重要事件披露

8-K - Current report
2022/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/04/29

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/08

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/08

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/06/30

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/06/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/18

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/20

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/22

SEC问询函

CORRESP [Cover] - Correspondence
2020/05/21

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/05/21

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/26

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/26

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]